Brustugun OT - Search Results

1

Real-World Data on EGFR and ALK Testing and TKI Usage in Norway-A Nation-Wide Population Study.

Eide IJZ, Nilssen Y, Stensland EM, Brustugun OT. Eide IJZ, et al. Among authors: brustugun ot. Cancers (Basel). 2023 Feb 27;15(5):1505. doi: 10.3390/cancers15051505. Cancers (Basel). 2023. PMID: 36900294 Free PMC article.

2

Injected cytochrome c induces apoptosis.

Zhivotovsky B, Orrenius S, Brustugun OT, Døskeland SO. Zhivotovsky B, et al. Among authors: brustugun ot. Nature. 1998 Jan 29;391(6666):449-50. doi: 10.1038/35060. Nature. 1998. PMID: 9461210 No abstract available.

3

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.

Fernandez-Cuesta L, Sun R, Menon R, George J, Lorenz S, Meza-Zepeda LA, Peifer M, Plenker D, Heuckmann JM, Leenders F, Zander T, Dahmen I, Koker M, Schöttle J, Ullrich RT, Altmüller J, Becker C, Nürnberg P, Seidel H, Böhm D, Göke F, Ansén S, Russell PA, Wright GM, Wainer Z, Solomon B, Petersen I, Clement JH, Sänger J, Brustugun OT, Helland Å, Solberg S, Lund-Iversen M, Buettner R, Wolf J, Brambilla E, Vingron M, Perner S, Haas SA, Thomas RK. Fernandez-Cuesta L, et al. Among authors: brustugun ot. Genome Biol. 2015 Jan 5;16(1):7. doi: 10.1186/s13059-014-0558-0. Genome Biol. 2015. PMID: 25650807 Free PMC article.

4

[Cancer treatment and COVID-19].

Brustugun OT. Brustugun OT. Tidsskr Nor Laegeforen. 2020 Apr 3;140(7). doi: 10.4045/tidsskr.20.0280. Print 2020 May 5. Tidsskr Nor Laegeforen. 2020. PMID: 32378865 Free article. Norwegian. No abstract available.

5

Membrane-permeant, bioactivatable analogues of cGMP as inducers of cell death in IPC-81 leukemia cells.

Schwede F, Brustugun OT, Zorn-Kruppa M, Døskeland SO, Jastorff B. Schwede F, et al. Among authors: brustugun ot. Bioorg Med Chem Lett. 2000 Mar 20;10(6):571-3. doi: 10.1016/s0960-894x(00)00050-0. Bioorg Med Chem Lett. 2000. PMID: 10741556

6

Sensitive and rapid detection of beta-galactosidase expression in intact cells by microinjection of fluorescent substrate.

Brustugun OT, Mellgren G, Gjertsen BT, Bjerkvig R, Døskeland SO. Brustugun OT, et al. Exp Cell Res. 1995 Aug;219(2):372-8. doi: 10.1006/excr.1995.1241. Exp Cell Res. 1995. PMID: 7641787

7

Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors.

Fladmark KE, Brustugun OT, Hovland R, Boe R, Gjertsen BT, Zhivotovsky B, Døskeland SO. Fladmark KE, et al. Among authors: brustugun ot. Cell Death Differ. 1999 Nov;6(11):1099-108. doi: 10.1038/sj.cdd.4400590. Cell Death Differ. 1999. PMID: 10578179

8

Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix.

Lyng H, Beigi M, Svendsrud DH, Brustugun OT, Stokke T, Kristensen GB, Sundfør K, Skjønsberg A, De Angelis PM. Lyng H, et al. Among authors: brustugun ot. Int J Cancer. 2004 Sep 1;111(3):358-66. doi: 10.1002/ijc.20258. Int J Cancer. 2004. PMID: 15221962 Free article.

9

Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by Bcl-2.

Brustugun OT, Fladmark KE, Doskeland SO, Orrenius S, Zhivotovsky B. Brustugun OT, et al. Cell Death Differ. 1998 Aug;5(8):660-8. doi: 10.1038/sj.cdd.4400399. Cell Death Differ. 1998. PMID: 10200521

10

The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.

Courter D, Cao H, Kwok S, Kong C, Banh A, Kuo P, Bouley DM, Vice C, Brustugun OT, Denko NC, Koong AC, Giaccia A, Le QT. Courter D, et al. Among authors: brustugun ot. PLoS One. 2010 Mar 10;5(3):e9633. doi: 10.1371/journal.pone.0009633. PLoS One. 2010. PMID: 20224789 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page